أدوية ومنتجات صحية
Cyclophosphamide for Injection USP: Presence of particulate matter
Summary
| Type | Health product recall |
|---|---|
| Product | Cyclophosphamide for Injection USP |
| Issue | Health products - Product quality |
| What to do | Consult your healthcare provider for any health concerns. |
| Distribution | National |
| Last updated | 2026-10-30 |
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Marcan Pharmaceuticals Inc |
Cyclophosphamide for Injection USP |
DIN 02560216 |
Powder for Solution |
1000 mg/vial |
7Z10346A |
Issue
| Presence of particulate matter in affected lot. |
What you should do
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Background
Depth of recall: Healthcare establishments
Details
| Original published date | 2026-11-02 | |
|---|---|---|
| Alert / recall type | Health product recall | |
| Category | Health products - Drugs | |
| Companies |
| |
| Published by | Health Canada | |
| Audience | General public Healthcare Industry | |
| Distribution | National | |
| Recall class | Type I | |
| Identification number | RA-82896 |
Source: Government of Canada, Recalls and safety alerts – https://recalls-rappels.canada.ca/en/alert-recall/cyclophosphamide-injection-usp-presence-particulate-matter